Related Experiment Video
Updated: Jun 24, 2026
11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Manganese(III)-salens induce tumor selective apoptosis in human cells
Khairul I Ansari1, James D Grant, Sahba Kasiri
1Department of Chemistry and Biochemistry, The University of Texas at Arlington, 76019, United States.
Journal of Inorganic Biochemistry
|March 20, 2009
Summary
New manganese(III)-salen derivatives show potent anti-tumor activity by inducing apoptosis in breast cancer cells. These compounds exhibit selective cytotoxicity, similar to cisplatin, highlighting their potential as novel therapeutic agents.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Manganese Complexes
Background:
- Metallo-salen complexes are investigated for their biological activities.
- Understanding the structure-activity relationship of these complexes is crucial for drug development.
Purpose of the Study:
- To synthesize and evaluate manganese(III)-salen derivatives for their apoptotic and anti-tumor effects.
- To assess the selectivity of these compounds against human cancer cells.
Main Methods:
- Synthesis of nine Mn(III)-salen derivatives.
- In vitro studies on cultured human cancer (MCF7) and non-cancer (MCF10) cells.
- Analysis of cell viability, nuclear morphology, caspase-3/7 activation, and cytochrome-c release.
Main Results:
- Mn(III)-salen derivatives induced apoptosis in MCF7 cells via the mitochondrial pathway.
- Cytotoxicity and selectivity were influenced by substituents and ligand structure.
- Selective cytotoxicity (2- to 5-fold) against MCF7 cells over MCF10 cells was observed.
- IC(50) values ranged from 11-40 μM in MCF7 cells.
Conclusions:
- Mn(III)-salen derivatives demonstrate significant apoptotic and anti-tumor activities.
- These compounds exhibit promising selective cytotoxicity against breast cancer cells.
- Mn(III)-salen derivatives represent potential novel anti-tumor agents with efficacy comparable to cisplatin.
